Ryan Ungaro, MD

For De-escalation of IBD Therapy, New Data Support Stopping Immunomodulators

If de-escalating IBD therapy, cutting out the immunomodulator but keeping the anti-TNF agent may be the best bet, ...

JULY 31, 2023

Load more